Blue Crest Capital Management LTD Nuvasive Inc Transaction History

Blue Crest Capital Management LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$47.43 - $60.75 $1.13 Million - $1.45 Million	-23,842 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$43.51 - $66.59 $1.18 Million - $1.81 Million	-27,158 Reduced 53.25%	23,842 $1.33 Million
Q1 2020 May 15, 2020	BUY	$32.82 - $81.13 $1.67 Million - $4.14 Million	51,000 New	51,000 $2.58 Million
Q2 2018 Aug 14, 2018	SELL	$48.15 - $56.68 $241,135 - $283,853	-5,008 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$46.03 - $61.28 $230,518 - $306,890	5,008 New	5,008 $261,000
Q4 2017 Feb 14, 2018	SELL	$50.58 - $60.79 $590,572 - $709,784	-11,676 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$53.54 - $68.0 $625,133 - $793,968	11,676	11,676 $648,000

116K

Ticker NUVA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 52,061,000
Description
NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...

Get notified when there are updates to the investment portfolio of Blue Crest Capital Management LTD, based on Form 13F filings with the SEC.

Stay updated on Blue Crest Capital Management LTD with notifications on news.